Baxter's H5N1 vaccine Celvapan recommended for EU approval
This article was originally published in Scrip
Executive Summary
Baxter's cell culture-based H5N1 (avian flu) pandemic vaccine Celvapan has been recommended for approval by the EU's CHMPfor the prophylaxis of influenza in an officially declared pandemic.